Antiinflammatory consequences of 5-lipoxygenase inhibition. 1986

N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D003877 Dermatitis, Contact A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms. Contact Dermatitis,Dermatitis Venenata,Eczema, Contact,Hypersensitivity, Contact,Sensitivity, Contact,Contact Dermatitides,Contact Eczema,Contact Hypersensitivities,Contact Hypersensitivity,Contact Sensitivities,Contact Sensitivity,Dermatitides, Contact,Hypersensitivities, Contact,Sensitivities, Contact
D004139 Dinitrofluorobenzene Irritants and reagents for labeling terminal amino acid groups. DNFB,Fluorodinitrobenzene,1-Fluoro-2,4-dinitrobenzene,1 Fluoro 2,4 dinitrobenzene
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001091 Arachidonate Lipoxygenases Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- . Arachidonic Acid Lipoxygenase,Lipoxygenase, Arachidonic Acid,Lipoxygenases, Arachidonate

Related Publications

N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
October 1987, European journal of pharmacology,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
March 1983, Prostaglandins,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
January 1999, Current medicinal chemistry,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
January 1999, Advances in experimental medicine and biology,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
August 1998, Molecular pharmacology,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
November 1985, FEBS letters,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
August 1990, Journal of medicinal chemistry,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
March 1993, Archiv der Pharmazie,
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
March 1990, Lancet (London, England),
N R Ackerman, and E C Arner, and W Galbraith, and R R Harris, and B D Jaffee, and W M Mackin
July 1988, Prostaglandins, leukotrienes, and essential fatty acids,
Copied contents to your clipboard!